Christopher Cruickshank

1.1k total citations · 1 hit paper
5 papers, 856 citations indexed

About

Christopher Cruickshank is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Christopher Cruickshank has authored 5 papers receiving a total of 856 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 2 papers in Cellular and Molecular Neuroscience and 1 paper in Pharmacology. Recurrent topics in Christopher Cruickshank's work include Neurotransmitter Receptor Influence on Behavior (2 papers), RNA Interference and Gene Delivery (1 paper) and Lipid Membrane Structure and Behavior (1 paper). Christopher Cruickshank is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (2 papers), RNA Interference and Gene Delivery (1 paper) and Lipid Membrane Structure and Behavior (1 paper). Christopher Cruickshank collaborates with scholars based in Australia and United Kingdom. Christopher Cruickshank's co-authors include Kyle R. Dyer, Boris Martinac, Rodney F. Minchin, Alexander C. Le Dain, Mark Montebello, Yan Chen, Heather A. E. Benson and David H. Brown and has published in prestigious journals such as Biophysical Journal, Addiction and Rapid Communications in Mass Spectrometry.

In The Last Decade

Christopher Cruickshank

5 papers receiving 832 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A review of the clinical pharmacology of methamphetamine

2009 549 citations Christopher Cruickshank, Kyle R. Dyer Addiction profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher Cruickshank Australia	5	326	305	153	130	126	5	856
Inger Lise Bogen Norway	17	328 1.0×	235 0.8×	139 0.9×	77 0.6×	79 0.6×	48	838
Caroline S. Copeland United Kingdom	16	206 0.6×	139 0.5×	121 0.8×	93 0.7×	55 0.4×	59	730
Peter Foley United Kingdom	16	247 0.8×	146 0.5×	45 0.3×	95 0.7×	138 1.1×	48	1.3k
Brett C. Ginsburg United States	16	485 1.5×	187 0.6×	150 1.0×	257 2.0×	62 0.5×	62	797
Gregory A. Schmunk United States	13	851 2.6×	328 1.1×	253 1.7×	138 1.1×	68 0.5×	22	1.3k
Nicholas E. Goeders United States	19	993 3.0×	381 1.2×	113 0.7×	120 0.9×	111 0.9×	62	1.4k
Eun Young Jang South Korea	21	391 1.2×	261 0.9×	24 0.2×	101 0.8×	240 1.9×	67	1.2k
Catherine Schmidt‐Mutter France	15	190 0.6×	164 0.5×	117 0.8×	27 0.2×	104 0.8×	34	659
S E Lukas United States	18	628 1.9×	276 0.9×	138 0.9×	172 1.3×	100 0.8×	31	1.0k
Kunio Yui Japan	18	427 1.3×	263 0.9×	108 0.7×	177 1.4×	94 0.7×	71	1.1k

Countries citing papers authored by Christopher Cruickshank

Since Specialization

Citations

This map shows the geographic impact of Christopher Cruickshank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Cruickshank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Cruickshank more than expected).

Fields of papers citing papers by Christopher Cruickshank

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Cruickshank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Cruickshank. The network helps show where Christopher Cruickshank may publish in the future.

Co-authorship network of co-authors of Christopher Cruickshank

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Cruickshank. A scholar is included among the top collaborators of Christopher Cruickshank based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Cruickshank. Christopher Cruickshank is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Benson, Heather A. E., et al.. (2011). Development of a liquid chromatography/mass spectrometry methodology to separate, detect, characterize and quantify PEG‐resveratrol prodrugs and the conjugation reaction precursors and intermediates. Rapid Communications in Mass Spectrometry. 25(11). 1543–1551. 6 indexed citations

2.

Cruickshank, Christopher & Kyle R. Dyer. (2009). A review of the clinical pharmacology of methamphetamine. Addiction. 104(7). 1085–1099. 549 indexed citations breakdown →

3.

Cruickshank, Christopher, et al.. (2008). A placebo‐controlled trial of mirtazapine for the management of methamphetamine withdrawal. Drug and Alcohol Review. 27(3). 326–333. 56 indexed citations

4.

Cruickshank, Christopher, et al.. (2005). Depression and other psychological health problems among methamphetamine dependent patients in treatment: Implications for assessment and treatment outcome. Australian Psychologist. 40(2). 96–108. 24 indexed citations

5.

Cruickshank, Christopher, Rodney F. Minchin, Alexander C. Le Dain, & Boris Martinac. (1997). Estimation of the pore size of the large-conductance mechanosensitive ion channel of Escherichia coli. Biophysical Journal. 73(4). 1925–1931. 221 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact